Búsqueda de un proyecto
Otra(s) opcion(es) de búsqueda
55 Resultado(s)
Financiado por un miembro del IRDiRC = Miembro de una ERN =
Proyectos de investigación

Madrid
ADDRESS: NOT PROVIDED - ES
Estudio prospectivo observacional sobre la supervivencia general y la calidad de vida en pacientes mayores de 60 años con diagnóstico de leucemia mieloide aguda en España, tratados de acuerdo con la práctica clínica estándar
Institution: Information not provided - ES

Baden-Württemberg
HEIDELBERG
INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

Baden-Württemberg
ULM
Dissection of the function of the "Lymphoid enhancer-binding factor 1" (Lef1) in acute myeloid leukemia (SFB 1074: Experimental Models and Clinical Translation in Leukemia9
Universitätsklinikum Ulm
Institut für Experimentelle Tumorforschung

Baden-Württemberg
ULM
Deciphering Critical Changes in the Methylome of Hematopoietic Stem Cells in Age-related Clonal Hematopoiesis and Myeloid Leukemogenesis (FOR 2674: Aging-related epigenetic remodeling in acute myeloid leukemia)
Universitätsklinikum Ulm
Institut für Experimentelle Tumorforschung

Baden-Württemberg
ULM
AMLSG BIO: Registry Study on Patient Characteristics, Biolo gical Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
Universitätsklinikum Ulm am Oberen Eselsberg
Klinik für Innere Medizin III

Nordrhein-Westfalen
BONN
Dissection of the function of the "Lymphoid enhancer-binding factor 1" (Lef1) in acute myeloid leukemia (SFB 1074: Experimental Models and Clinical Translation in Leukemia9
Deutsche Forschungsgemeinschaft

Nordrhein-Westfalen
BONN
Deciphering Critical Changes in the Methylome of Hematopoietic Stem Cells in Age-related Clonal Hematopoiesis and Myeloid Leukemogenesis (FOR 2674: Aging-related epigenetic remodeling in acute myeloid leukemia)
Deutsche Forschungsgemeinschaft

NIEDERÖSTERREICH
KREMS AN DER DONAU
STAT3 isoforms in acute myeloid leukemia
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
Fachbereich Pharmakologie

OBERÖSTERREICH
LINZ
AMLSG BiO: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project - AT
Ordensklinikum Linz GmbH Barmherzige Schwestern
Interne I - Internistische Onkologie, Hämatologie u. Gastroenterologie

STEIERMARK
GRAZ
Subclonal TP53 mutations in acute myeloid leukemia
Medizinische Universität Graz
Klinische Abteilung für Hämatologie

WIEN
ADDRESS: NOT PROVIDED - AT
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - AT
Institution: Information not provided - AT

WIEN
WIEN
Charting and Disrupting the Gene-Regulatory Function of CDK6
AKH BT 25.3
Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences

WIEN
WIEN
Find tumor immune evasion strategies by cellular barcoding
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
Linking CDK6 to the epigenome in AML (acute myeloid leukemia)
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

WIEN
WIEN
ONCOMECHAML: Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia - AT
Veterinärmedizinische Universität Wien
Institut für Medizinische Biochemie

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MicroAML: Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia
Metabolism & Nutrition (MNut), Louvain Drug Institute
Metabolism & Nutrition

Ontario
TORONTO
CD123-Targeted Auger Electron Radioimmunotherapy of Acute Myelogenous Leukemia (AML)
University of Toronto
Leslie Dan Faculty of Pharmacy, University of Toronto

Castilla - León
SALAMANCA
Perfil genómico integrado DNA/RNA como estrategia para el diagnostico de la leucemia mieloblástica aguda. Monitorización molecular de EMR mediante técnicas de alta sensibilidad
IBSAL - Instituto de Investigación Biomédica de Salamanca
Biología molecular y celular de hemopatías

Navarra
PAMPLONA
Redes transcripcionales y reguladoras génicas en la leucemia mieloide aguda secundaria a síndromes mielodisplásicos: identificación de nuevas dianas terapéuticas
CIMA - Centro de Investigación Médica Aplicada
Grupo de Patología Mieloide

Washington
ADDRESS: NOT PROVIDED - US
Therapeutics for rare and neglected diseases - science
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The development of multikinase inhibitors for the treatment of selected cancers
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanistic and translational studies of cbf leukemia
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Molecular pathogenesis of chromosome 16 inversion in human leukemia
Institution: Information not provided - US

EMILIA ROMAGNA
MELDOLA
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Greater London
SURREY
Assessing Feasibility of Expansion and Characterization of Gamma Delta T Cells From Peripheral Blood and Bone Marrow of Patients With Acute Myeloid Leukaemia as Starting Product for Generation of CD33-CD28 Gamma Delta T Cells-GB
The Royal Marsden
Royal Marsden NHS Foundation Trust

Region Stockholm
HUDDINGE
Molecular pathogenesis in myelodysplastic syndromes and acute myeloid leukemia
Karolinska Institutet - Huddinge
Department of Medicine

Region Stockholm
STOCKHOLM
Study of chemotherapy resistance and DNA methylation in acute myeloid leukemia samples
Karolinska Universitetssjukhuset - Huddinge
Hematology Centre

Baden-Württemberg
FREIBURG
MyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Pädiatrische Hämatologie und Onkologie

Baden-Württemberg
TÜBINGEN
MyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

Niedersachsen
HANNOVER
MyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Medizinische Hochschule Hannover
Institut für Humangenetik

Nordrhein-Westfalen
DÜSSELDORF
MyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Universitätsklinikum Düsseldorf
Klinik für Kinder-Onkologie, -Hämatologie und klinische Immunologie

Sachsen-Anhalt
HALLE (SAALE)
MyPred: Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia
Universitätsklinikum Halle (Saale)
Universitätsklinik und Poliklinik für Pädiatrie I

Suisse Alémanique
ZÜRICH
The Swiss Pediatric Hematology/ Oncology Metabank - a network for precision medicine research
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)

Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US

ILE-DE-FRANCE
ORSAY
DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS
Proyectos de investigación multicéntricos
- Universitätsklinikum Mannheim
- European Leukemia Net - Network Management Center
- Institution: Information not provided - IT
- Institution: Information not provided - IT
- Institution: Information not provided - IT
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - DE
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- University Hospital of Wales
- Department of Haematology
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine

Baden-Württemberg
MANNHEIM
EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
DRAMA: Defeating Recurrence and resistance in AML: Multigenomic Approaches to analyse heterogeneity

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
HLALOSS: New technologies for early detection of HLA loss leukemia relapse after allogeneic hematopoietic stem cell transplantation, and identification of relevant risk factors.

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
HAPLO-IMMUNE: Validation of immune biomarkers predictive of clinical outcome after HLA-haploidentical hematopoietic stem cell transplantation for acute leukemia

WIEN
WIEN
ENCCA: European Network for Cancer Research in Children and Adolescents

Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology

WIEN
WIEN
DIRECT: disseminate research funded by EC improving treatment options for children suffering from cancer

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities

LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe

LOMBARDIA
MILANO
RARECARENet: Information network on rare cancers

South Glamorgan
CARDIFF
South East Wales Cancer Network

Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium

ILE-DE-FRANCE
ORSAY